| Tretinoin | Approved Investigational Nutraceutical | PMAIP1 | 5366 |
upregulated | Tretinoin results in increased expression of PMAIP1 mRNA | 18q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | PMEL | 6490 |
downregulated | Tretinoin results in decreased expression of PMEL mRNA | 12q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PML | 5371 |
downregulated | Tretinoin results in decreased expression of PML mRNA | 15q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PMP22 | 5376 |
downregulated | Tretinoin results in decreased expression of PMP22 mRNA | 17p12 | |
| Tretinoin | Approved Investigational Nutraceutical | PNKD | 25953 |
upregulated | Tretinoin results in increased expression of PNKD mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | PNMA2 | 10687 |
downregulated | Tretinoin results in decreased expression of PNMA2 mRNA | 8p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PNMT | 5409 |
downregulated | Tretinoin results in decreased expression of PNMT mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | PNN | 5411 |
downregulated | Tretinoin results in decreased expression of PNN mRNA | 14q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PNO1 | 56902 |
downregulated | Tretinoin results in decreased expression of PNO1 mRNA | 2p14 | |
| Tretinoin | Approved Investigational Nutraceutical | PNP | 4860 |
downregulated | Tretinoin results in decreased expression of PNP mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PNRC1 | 10957 |
upregulated | Tretinoin results in increased expression of PNRC1 mRNA | 6q15 | |
| Tretinoin | Approved Investigational Nutraceutical | PODXL | 5420 |
downregulated | Tretinoin results in decreased expression of PODXL mRNA | 7q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | POFUT2 | 23275 |
upregulated | Tretinoin results in increased expression of POFUT2 mRNA | 21q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | POLD3 | 10714 |
downregulated | Tretinoin results in decreased expression of POLD3 mRNA | 11q13.4 | |
| Tretinoin | Approved Investigational Nutraceutical | POLD4 | 57804 |
upregulated | Tretinoin results in increased expression of POLD4 mRNA | 11q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | POLE2 | 5427 |
downregulated | Tretinoin results in decreased expression of POLE2 mRNA | 14q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | POLR1B | 84172 |
downregulated | Tretinoin results in decreased expression of POLR1B mRNA | 2q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | POLR1C | 9533 |
downregulated | Tretinoin results in decreased expression of POLR1C mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | POLR2H | 5437 |
downregulated | Tretinoin results in decreased expression of POLR2H mRNA | 3q27.1 | |
| Tretinoin | Approved Investigational Nutraceutical | POLR3D | 661 |
downregulated | Tretinoin results in decreased expression of POLR3D mRNA | 8p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | POLR3G | 10622 |
downregulated | Tretinoin results in decreased expression of POLR3G mRNA | 5q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | POLR3K | 51728 |
upregulated | Tretinoin results in increased expression of POLR3K mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PON2 | 5445 |
downregulated | Tretinoin results in decreased expression of PON2 mRNA | 7q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | POPDC3 | 64208 |
upregulated | Tretinoin results in increased expression of POPDC3 mRNA | 6q21 | |
| Tretinoin | Approved Investigational Nutraceutical | POR | 5447 |
upregulated | Tretinoin results in increased expression of POR mRNA | 7q11.23 | |